About this trial
Alcohol activates reward systems in different brain areas, i.e., the nucleus accumbens, dorsal striatum, extended amygdala, and prefrontal cortex. These areas are all part of the reward neurocircuitry, which plays an important role in the development of addiction.
A former study performed on rodents has shown that a specific area of the forebrain, the septal nuclei, is associated with the feeling of reward and, hence, addiction when stimulated. However, whether the septal area is involved in reward and addiction in humans is sparsely investigated.
The purpose of this brain-imaging study is to assess how the septal nuclei react to alcohol-related pictures shown to participants diagnosed with alcohol use disorder while lying in an MRI scanner, compared to people without a diagnosis of alcohol use disorder. This might give us a better understanding of how the septal nuclei is involved in reward and addiction.
Eligibility criteria
Qualifiers
Diagnosed with alcohol use disorder (AUD) according to DSM-5, and alcohol dependence according to ICD-10
An Alcohol Use Disorder Identification Test (AUDIT) score ≥ 15
At least six heavy drinking days for the last 30 days, measured with the Time Line Follow Back (TLFB) method
Disqualifiers
Diagnosis of schizophrenia spectrum disorder, paranoid psychosis, bipolar disorder, or mental retardation
Previous or current substance use disorder other than AUD and nicotine use disorder
History of alcohol withdrawal seizures within the past 5 years
Alcohol withdrawal symptoms defined as a CIWA-Ar score > 9 at screening or at the fMRI session
Trial design
Treatments tested in this trial
- Brain imaging
Treatment groups
Sponsors and collaborators
Anders Fink-Jensen, MD, DMSci
Lead sponsor
Psychiatric Centre Rigshospitalet
Sponsor institution
Neurobiology Research Unit, Rigshospitalet
Collaborator
The foundation of Mr. Ivan Nielsen
Collaborator
King Christian X foundation
Collaborator